5-Amino-1MQ vs Selank

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

5-Amino-1MQSelank
CategoryPeptidesPeptides
Standard DoseResearch indicates 50-150 mg daily via oral administration, typically divided into 1-2 doses.Research indicates 250-500 mcg daily via intranasal administration (0.15% solution, 2-3 drops per nostril).
TimingMorning dosing preferred. Can be taken with or without food.Can be dosed morning through evening. Unlike Semax, Selank is calming and can be used at night.
Cycle Duration8-12 week cycles.14-21 day cycles with equal rest periods.
Evidence Levelanimal_plus_anecdotalmoderate_human
A

5-Amino-1MQ

Peptides

Mechanism

5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, generating 1-methylnicotinamide (1-MNA). By inhibiting NNMT, 5-Amino-1MQ increases intracellular NAD+ levels, reduces 1-MNA production, suppresses lipogenesis in adipocytes, and modulates the methionine-homocysteine cycle. In vivo, it significantly reduces body weight, white adipose mass, and adipocyte size through enhanced energy expenditure and altered lipid metabolism.

Standard Dosing

Research indicates 50-150 mg daily via oral administration, typically divided into 1-2 doses.

Timing

Morning dosing preferred. Can be taken with or without food.

Cycle Duration

8-12 week cycles.

Side Effects

  • Mild GI discomfort
  • Headache
  • Diarrhea (uncommon)
  • Nausea at higher doses

Contraindications

  • Pregnancy and breastfeeding
  • Severe hepatic impairment
  • Active cancer (NAD+ modulation concern)

Best Stacking Partners

MOTS-cAOD-9604TesofensineSemaglutide
B

Selank

Peptides

Mechanism

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin (from IgG heavy chain) with a Pro-Gly-Pro extension for metabolic stability. It allosterically modulates GABA-A receptors, enhancing GABA binding and GABAergic neurotransmission. Selank modifies mRNA levels of 84 genes involved in GABAergic neurotransmission in the frontal cortex, enhances enkephalinase inhibition (increasing endogenous enkephalin levels), and modulates serotonergic and noradrenergic systems to produce anxiolytic and nootropic effects.

Standard Dosing

Research indicates 250-500 mcg daily via intranasal administration (0.15% solution, 2-3 drops per nostril).

Timing

Can be dosed morning through evening. Unlike Semax, Selank is calming and can be used at night.

Cycle Duration

14-21 day cycles with equal rest periods.

Side Effects

  • Mild nasal irritation
  • Fatigue/sedation (uncommon)
  • Mild headache

Contraindications

  • Pregnancy and breastfeeding
  • Severe hepatic impairment

Best Stacking Partners

SemaxBPC-157Thymosin Alpha-1

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →